111 Inc
NASDAQ:YI
111 Inc
Income from Continuing Operations
111 Inc
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
111 Inc
NASDAQ:YI
|
Income from Continuing Operations
-¥353.4m
|
CAGR 3-Years
9%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
Income from Continuing Operations
¥1.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
LBX Pharmacy Chain JSC
SSE:603883
|
Income from Continuing Operations
¥1.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
Yunnan Jianzhijia Health-Chain Co Ltd
SSE:605266
|
Income from Continuing Operations
¥363.4m
|
CAGR 3-Years
30%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
Income from Continuing Operations
¥1.6B
|
CAGR 3-Years
21%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
|
Income from Continuing Operations
¥563.6m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
See Also
What is 111 Inc's Income from Continuing Operations?
Income from Continuing Operations
-353.4m
CNY
Based on the financial report for Dec 31, 2023, 111 Inc's Income from Continuing Operations amounts to -353.4m CNY.
What is 111 Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
2%
Over the last year, the Income from Continuing Operations growth was 6%. The average annual Income from Continuing Operations growth rates for 111 Inc have been 9% over the past three years , 2% over the past five years .